ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Hydrochloric Acid → N-(4'-Amino-5'-methylspiro[chroman-4,2'-imidazole]-6-yl)-5-chloropicolinamide

HRID 1965085
印刷

反応式

HRID 1965085 の反応式
Cl.CN(C)CCCN=C=NCC.[Cl:13][C:14]1[CH:15]=[CH:16][C:17]([C:20]([OH:22])=O)=[N:18][CH:19]=1.[CH3:23][C:24]1[C:25]([NH2:39])=[N:26][C:27]2([C:37]3[C:32](=[CH:33][CH:34]=[C:35]([NH2:38])[CH:36]=3)[O:31][CH2:30][CH2:29]2)[N:28]=1.Cl>C(Cl)Cl.CN(C=O)C>[NH2:39][C:25]1[C:24]([CH3:23])=[N:28][C:27]2([C:37]3[C:32](=[CH:33][CH:34]=[C:35]([NH:38][C:20](=[O:22])[C:17]4[CH:16]=[CH:15][C:14]([Cl:13])=[CH:19][N:18]=4)[CH:36]=3)[O:31][CH2:30][CH2:29]2)[N:26]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 313Hydrochloric AcidHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 27628725-Chloro-2-picolinic acidHCID 679794075'-Methylspiro[chromane-4,2'-imidazole]-4',6-diamine2 回

生成物 1

HCID 57385111N-(4'-Amino-5'-methylspiro[chroman-4,2'-imidazole]-6-yl)-5-chloropicolinamide収率 31.7%

試薬・触媒・溶媒 2

HCID 6228Dimethylformamide溶媒HCID 6344Dichloromethane溶媒

実験手順

N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (58 mg, 0.30 mmol) was added to a suspension of 5-chloropyridine-2-carboxylic acid (37 mg, 0.23 mmol) in DCM (1.5 mL). The obtained solution was stirred for 10 min and added dropwise over 2 min to an ice-cooled solution of 5′-methylspiro[chroman-4,2′-imidazole]-4′,6-diamine (Intermediate 30, 54 mg, 0.23 mmol) and 2 M HCl (0.117 mL, 0.23 mmol) in DMF (1.5 mL). The mixture was stirred at 0° C. for 5 min. Volatiles were removed in vacuo, and the residue was purified by preparative chromatography. Fractions containing the product were combined, and the organic solvent was removed in vacuo. The aqueous residue was alkalized with (sat) NaHCO3 and then extracted twice with EtOAc. The combined organic phases were dried (Na2SO4) and evaporated to give a product which was purified by flash chromatography (4 g, gradient elution (EtOAc/MeOH/conc. NH3) in heptane) affording the title compound (27 mg, 31% yield). 1H NMR (400 MHz, DMSO-d6) δ ppm 1.92 (br. s., 2 H), 2.23 (s, 3 H), 4.23-4.54 (m, 2 H), 6.56 (br. s., 2 H), 6.80 (d, 1 H), 7.05 (br. s., 1 H), 7.54-7.72 (m, 1 H), 8.04-8.12 (m, 1 H), 8.13-8.23 (m, 1 H), 8.72 (br. s., 1 H), 10.41 (s, 1 H); HPLC, MS (APCI1) m/z 370 [M+H]1.

後処理

  1. stirringThe mixture was stirred at 0° C. for 5 min
  2. customVolatiles were removed in vacuo
  3. customthe residue was purified by preparative chromatography
  4. additionFractions containing the product
  5. customthe organic solvent was removed in vacuo
  6. extractionextracted twice with EtOAc
  7. dry with materialThe combined organic phases were dried (Na2SO4)
  8. customevaporated
  9. customto give a product which
  10. customwas purified by flash chromatography (4 g, gradient elution (EtOAc/MeOH/conc. NH3) in heptane)

出典と根拠

ORDレコード
ord-3b94e9ad3cbe4e7e85a014ab91f43662
出典データセット
uspto-grants-2013_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08415483B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート